VA ECMO for severe acute heart failure in adults

have the potential to recover, or as a bridge to having a heart transplant or an implanted left ventricular assist device. Unlike a heartâ€“lung (cardiopulmonary) bypass machine, it tends to be used for days to weeks, not hours during open heart surgery. This allows the heart time to recover. The aim is to improve patient outcomes. The evidence 3.4 NICE did a rapid review of the published literature on the efficacy and safety of this procedure. This comprised a comprehensive literature search and a detailed review of the evidence from 14 sources (16 publications), which was discussed by the committee. The evidence included 7 systematic reviews, 3 randomised controlled trials, 1 retrospective registry study, 2 single centre retrospective studies, and 1 review and case series. It is presented in the summary of key evidence section in the interventional procedures overview. Other relevant literature is in the appendix of the overview. 3.5 The professional experts and the committee considered the key efficacy outcomes to be: survival, restoration of organ function, and bridging to recovery, transplant or long-term support. 3.6 The professional experts and the committee considered the key safety outcomes to be: bleeding, leg ischaemia, stroke, infection, kidney failure and circuit-related
